Details
Stereochemistry | RACEMIC |
Molecular Formula | C20H30N2O2 |
Molecular Weight | 330.4644 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(OCCN1CCCCC1)C(N2CCCCC2)C3=CC=CC=C3
InChI
InChIKey=CGYQGGSMYNXXIV-UHFFFAOYSA-N
InChI=1S/C20H30N2O2/c23-20(24-17-16-21-12-6-2-7-13-21)19(18-10-4-1-5-11-18)22-14-8-3-9-15-22/h1,4-5,10-11,19H,2-3,6-9,12-17H2
Molecular Formula | C20H30N2O2 |
Molecular Weight | 330.4644 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[Clinical study of an antispasmodic with a predominantly musculotropic action: 2-piperidinoethyl alpha-phenyl-alpha-piperidinoacetate dihydrochloride (dipiproverine hydrochloride)]. | 1959 |
|
[Study, in digestive pathology, of a new spasmolytic drug with predominatly musculotropic action: dihydrochloride of di-dipiproverine (L.D. 935)]. | 1960 Feb 28 |
|
[THE USE OF DIPIPROVERINE DURING THE VICHY THERMAL CURE IN THE TREATMENT OF BILIARY DYSKINESIA AND SPASMODIC COLOPATHIES. (DOCUMENTARY AND STATISTICAL STUDY APROPOS OF 98 CASES)]. | 1964 Jun-Jul |
|
[CLINICAL TRIAL OF LEVOSPASM IN CANCER PATIENTS]. | 1964 Sep |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:21:45 GMT 2023
by
admin
on
Fri Dec 15 16:21:45 GMT 2023
|
Record UNII |
4XV7PTW3FZ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29698
Created by
admin on Fri Dec 15 16:21:45 GMT 2023 , Edited by admin on Fri Dec 15 16:21:45 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m152
Created by
admin on Fri Dec 15 16:21:45 GMT 2023 , Edited by admin on Fri Dec 15 16:21:45 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000082330
Created by
admin on Fri Dec 15 16:21:45 GMT 2023 , Edited by admin on Fri Dec 15 16:21:45 GMT 2023
|
PRIMARY | |||
|
C65427
Created by
admin on Fri Dec 15 16:21:45 GMT 2023 , Edited by admin on Fri Dec 15 16:21:45 GMT 2023
|
PRIMARY | |||
|
866
Created by
admin on Fri Dec 15 16:21:45 GMT 2023 , Edited by admin on Fri Dec 15 16:21:45 GMT 2023
|
PRIMARY | |||
|
DTXSID30861747
Created by
admin on Fri Dec 15 16:21:45 GMT 2023 , Edited by admin on Fri Dec 15 16:21:45 GMT 2023
|
PRIMARY | |||
|
CHEMBL2110899
Created by
admin on Fri Dec 15 16:21:45 GMT 2023 , Edited by admin on Fri Dec 15 16:21:45 GMT 2023
|
PRIMARY | |||
|
4XV7PTW3FZ
Created by
admin on Fri Dec 15 16:21:45 GMT 2023 , Edited by admin on Fri Dec 15 16:21:45 GMT 2023
|
PRIMARY | |||
|
3737
Created by
admin on Fri Dec 15 16:21:45 GMT 2023 , Edited by admin on Fri Dec 15 16:21:45 GMT 2023
|
PRIMARY | |||
|
117-30-6
Created by
admin on Fri Dec 15 16:21:45 GMT 2023 , Edited by admin on Fri Dec 15 16:21:45 GMT 2023
|
PRIMARY | |||
|
72072
Created by
admin on Fri Dec 15 16:21:45 GMT 2023 , Edited by admin on Fri Dec 15 16:21:45 GMT 2023
|
PRIMARY | |||
|
SUB07216MIG
Created by
admin on Fri Dec 15 16:21:45 GMT 2023 , Edited by admin on Fri Dec 15 16:21:45 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |